跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Tacrolimus Sustained-release Capsules
Approved
化学药品
Tacrolimus Sustained-release Capsules
ASTELLAS PHARMA EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Mar 5, 2020
Approval ID
7LeagRxHBf2
Company
ASTELLAS PHARMA EUROPE B.V.
Type
化学药品
Approval Details
Approval Id
7LeagRxHBf2
Approval Number
国药准字J20150057
Generic Name
他克莫司缓释胶囊
Generic Name En
Tacrolimus Sustained-release Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
5mg
Reg Date
2020-03-05
Company Name
ASTELLAS PHARMA EUROPE B.V.
Company Address
Sylviusweg 62,2333 BE Leiden, The Netherlands
Production Company Name
astellas ireland co.,ltd.
Production Company Address
Killorglin,Co kerry,V93 FC86,Ireland
Company Detail Path
/organization/astellas-pharma-europe-b-v
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 5, 2020
Approval ID
7LeagRxHBf2
Type
化学药品
Back to NMPA Approvals
他克莫司缓释胶囊 - NMPA Drug Approval Details